National Vision Holdings Retained Earnings (Accumulated Deficit) 2015-2024 | EYE

National Vision Holdings retained earnings (accumulated deficit) from 2015 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.

National Vision Holdings Retained Earnings (Accumulated Deficit) 2015-2024 | EYE

National Vision Holdings retained earnings (accumulated deficit) from 2015 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$202B
Stryker (SYK)$147.6B
Boston Scientific (BSX)$130.8B
Medtronic (MDT)$113.2B
EssilorLuxottica (ESLOY)$110B
Lonza Group Ag (LZAGY)$45.7B
Haleon (HLN)$42B
GE HealthCare Technologies (GEHC)$38.8B
ResMed (RMD)$36.3B
Terumo (TRUMY)$29.9B
Koninklijke Philips (PHG)$24.4B
Zimmer Biomet Holdings (ZBH)$21.9B
Insulet (PODD)$19.3B
Baxter (BAX)$17.3B
Smith & Nephew SNATS (SNN)$10.7B
Bio-Rad Laboratories (BIO)$10.2B
BellRing Brands (BRBR)$9.3B
Demant (WILYY)$8.3B
Lantheus Holdings (LNTH)$5.9B
TG Therapeutics (TGTX)$4.8B
Haemonetics (HAE)$4.7B
ICU Medical (ICUI)$4.3B
Prestige Consumer Healthcare (PBH)$4B
Perrigo (PRGO)$3.6B
Envista Holdings (NVST)$3.5B
Agios Pharmaceuticals (AGIO)$3.4B
Neogen (NEOG)$3.3B
Shandong Weigao Medical Polymer (SHWGF)$3B
GN Store Nord (GNNDY)$3B
QuidelOrtho (QDEL)$2.8B